/
CRON
$2.85+$0.04 (+1.42%)live
Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$1.0B
374M shares
52-week range
$1.89 – $3.43
62% from low
Sector
MEDICINAL CHEMICALS & BOTANICAL PRODUCTS
Exchange
NASDAQ
CS
Borrow rate
1.54%
Moderate
Price (6 mo)
Loading chart…
Change$-5.75
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $12.1M | $17.8M | $46.7M | $64.6M | $86.7M | $87.2M | $117.6M | $149.2M |
| Cost of revenue | $5.9M | $31.1M | $72.6M | $82.2M | $71.3M | $75.3M | $92.4M | $87.5M |
| Gross profit | $6.2M | −$13.2M | −$25.8M | −$17.6M | $15.4M | $11.9M | $25.2M | $61.7M |
| Gross margin | 51.3% | -74.1% | -55.3% | -27.3% | 17.8% | 13.7% | 21.4% | 41.4% |
| R&D | $1.7M | $9.1M | $20.4M | $21.8M | $13.1M | $5.8M | $4.2M | $4.4M |
| Operating income | −$20.4M | −$115.1M | −$219.4M | −$292.0M | −$111.4M | −$84.8M | −$76.5M | −$17.8M |
| EBITDA | −$18.8M | $879.8M | −$66.0M | −$150.1M | −$91.3M | −$71.8M | −$50.2M | −$3.4M |
| Net income | −$21.6M | $876.1M | −$73.1M | −$396.1M | −$168.7M | −$74.0M | $41.1M | −$9.6M |
| Net margin | -178.5% | 4911.6% | -156.5% | -613.5% | -194.5% | -84.8% | 34.9% | -6.4% |
| EPS (diluted) | -0.16 | 3.41 | -0.21 | -1.07 | -0.45 | -0.19 | 0.11 | -0.03 |
Annual figures · source: Financial Modeling Prep
Analyst estimates (consensus)
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $196M | $0.09 | $0.08–$0.10 | 3 |
| 2027 | $222M | $0.11 | $0.10–$0.12 | 3 |
| 2028 | $226M | $0.14 | $0.13–$0.14 | 2 |
| 2029 | $199M | $0.15 | $0.14–$0.16 | 1 |
Forward consensus · source: Financial Modeling Prep
Peer comparison
Cronos Group Inc. Common Share
Cronos Group Inc is a cannabinoid company committed to building disruptive intellectual property by advancing cannabis research, technology, and product development. With a passion for responsibly elevating the consumer experience, the company is building an iconic brand portfolio. Its diverse international brand portfolio includes Spinach, PEACE NATURALS, LIT, and Lord Jones. The company operates in Canada, Israel, and other countries, with the majority of its revenue generated from Canada.
www.thecronosgroup.com- Employees
- 610
- IPO / List date
- Jun 3, 2016
- HQ
- STAYNER, A6
Held by traders on TradeandTell
No one on the platform currently holds CRON.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 2,009,549 | $5.0M |
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded CRON yet.
